|
Mesothelioma
Treatment
Mesothelioma
Alerts
Arthritis
Drug Shows Promising Effects For
Mesothelioma Victims
Researchers
in Italy have discovered that studies
involving Pfizer Inc.'s arthritis drug
Celebrex have shown promising results in
combating the effects of cancerous cell
growth related to the asbestos-induced
disease mesothelioma.
Interscience.Wiley.com
May 19, 2004
FDA
approves Alimta-Cisplatin Combination for
treatment of Asbestos-Related
Cancer
The
first and only drug regimen proven to help
patients with an asbestos-related cancer
live longer was approved today by the U.S.
Food and Drug Administration.
Press
Release
February 2, 2004
Implantable
Device May Offer Better Pain
Management
Patients
with advanced cancer who used an
implantable drug-delivery device to
control their pain had better pain relief,
fewer toxic side effects, and better
survival than patients who received
intensive medical pain management,
researchers reported in the October 1,
2002, issue of the Journal of Clinical
Oncology.
National
Cancer Institute
October 23, 2002
Experimental
Cancer Drug Tarceva
OSI
Pharmaceuticals Inc. is more confident
than ever of the potential of its
experimental cancer drug Tarceva
(erlotinib HCl), even after the failure of
a similar drug in a major clinical study
this summer, OSI Chairman and CEO Dr.
Colin Goddard told investors at the UBS
Warburg Global Life Sciences conference
here on Wednesday.
Reuters
October 9, 2002
Chemotherapy
Combination Promising For
Mesothelioma
A
new chemotherapy combination has shown
"remarkable" activity against mesothelioma
in an early study, British researchers
reported on Tuesday.
Journal
of Clinical Oncology
August 26, 2002
If
you have any other questions, please feel
free to contact
us.
| 
